BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 31002164)

  • 1. MicroRNA-129-5p inhibits invasiveness and metastasis of lung cancer cells and tumor angiogenesis via targeting VEGF.
    Cheng XK; Lin WR; Jiang H; Su ZH; Li L; Wang J
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2827-2837. PubMed ID: 31002164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA-199 inhibits malignant progression of lung cancer through mediating RGS17.
    Su WZ; Ren LF
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3390-3400. PubMed ID: 31081094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of LncRNA FOXC2-AC1 promoting lung cancer metastasis by regulating miR-107.
    Wu XF; Lu JT; Chen W; Wang N; Meng JC; Zhou YH
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):690-698. PubMed ID: 30720176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-424-5p inhibits the development of non-small cell LCa by binding to ITGB1.
    Xu ZL; Zhang M; Chen SX; Qiu M; Zhang Q; Gao LP; Li JDX
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8921-8930. PubMed ID: 31696479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA-217 inhibits proliferation of hepatocellular carcinoma cells by regulating KLF5.
    Gao W; Lu YX; Wang F; Sun J; Bian JX; Wu HY
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7874-7883. PubMed ID: 31599412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-374b inhibits migration and invasion of glioma cells by targeting EGFR.
    Pan DS; Cao P; Li JJ; Fan D; Song ZQ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4254-4263. PubMed ID: 31173297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-337-5p participates in the development and progression of osteosarcoma via ERBB, MAPK and VEGF pathways.
    Tian ZG; Zhuang Y; Jin Z; Zhou F; Zhu LF; Shen PC
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5460-5470. PubMed ID: 30229817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
    Pan MZ; Song YL; Gao F
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8795-8805. PubMed ID: 31696466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-625-3p inhibits gastric cancer metastasis through modulating EZH2.
    Li Y; Zhou HC; Zhang Y; Huang H
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1177-1185. PubMed ID: 32096165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiRNA-8073 targets ZnT1 to inhibit malignant progression of ovarian cancer.
    Zhang L; Wang YH; Wang L
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6062-6069. PubMed ID: 31364107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-203 promotes the progression of non-small cell lung cancer via surviving.
    Wang T; Li W; Li W; Liu L; Zhang H
    J BUON; 2019; 24(2):591-598. PubMed ID: 31128011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-9-5p could promote angiogenesis and radiosensitivity in cervical cancer by targeting SOCS5.
    Wei YQ; Jiao XL; Zhang SY; Xu Y; Li S; Kong BH
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7314-7326. PubMed ID: 31539118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-588 regulates migration capacity and invasiveness of renal cancer cells by targeting EIF5A2.
    Dong JS; Wu B; Zha ZL
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10248-10256. PubMed ID: 31841179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR‑1 inhibits the progression of colon cancer by regulating the expression of vascular endothelial growth factor.
    Zhu D; Sun Y; Zhang D; Dong M; Jiang G; Zhang X; Zhou J
    Oncol Rep; 2018 Aug; 40(2):589-598. PubMed ID: 29845255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
    Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA BX357664 inhibits the proliferation and invasion of non-small cell lung cancer cells.
    Yang J; Du YM; Li B
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):660-669. PubMed ID: 30720174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircABCB10 promotes the proliferation and migration of lung cancer cells through down-regulating microRNA-217 expression.
    Hu TY; Zhu QX; Duan QY; Jin XY; Wu R
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6157-6165. PubMed ID: 32572881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-135 inhibits gastric cancer metastasis by targeting SMAD2.
    He Y; Wu L; Dai Y; Li J; Liu S
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9436-9444. PubMed ID: 31773690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.